Humacyte, Inc.
HUMA
$1.47
-$0.03-2.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -37.66M | 39.14M | -20.94M | -39.20M | -56.66M |
| Total Depreciation and Amortization | 1.86M | 1.83M | 1.81M | 1.81M | 1.78M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.78M | -60.01M | -4.94M | 11.07M | 29.54M |
| Change in Net Operating Assets | -1.40M | -9.56M | -2.50M | 3.41M | 4.06M |
| Cash from Operations | -26.41M | -28.60M | -26.58M | -22.91M | -21.29M |
| Capital Expenditure | -568.00K | -228.00K | -63.00K | -934.00K | -184.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -568.00K | -228.00K | -63.00K | -934.00K | -184.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -727.00K | -687.00K | -673.00K | -659.00K | -644.00K |
| Issuance of Common Stock | 3.23M | 47.43M | 50.16M | 495.00K | 787.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -340.00K | -- | 1.52M | 1.01M | -610.00K |
| Cash from Financing | 2.17M | 46.74M | 51.01M | 849.00K | -467.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24.82M | 17.91M | 24.37M | -22.99M | -21.94M |